Skip to content

Bone Remodeling Around Implants With Two Different Surfaces Placed in Horizontally Augmented Bone

Clinical and Radiographic Evaluation of Bone Remodeling Around Implants With Two Different Surfaces Placed in Horizontally Augmented Bone: a 1-year Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04343066
Enrollment
15
Registered
2020-04-13
Start date
2019-04-15
Completion date
2020-12-30
Last updated
2020-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Remodeling, Dental Implantation

Keywords

Alveolar ridge augmentation, Dental implants, Marginal bone remodeling

Brief summary

The aim of this prospective controlled clinical trial is to evaluate the clinical and radiographical outcomes of two implant surfaces inserted in a crest that has been horizontally augmented at least 6 months prior to the implant placement. The horizontal GBR should be done with a xenogenic graft mixed with autologous bone particles, and a collagen membrane stabilized using tacks or screws.

Detailed description

This is a prospective, randomized clinical and radiographical evaluation of bone remodeling around implants with two different surfaces placed in a previously augmented crest. Patients requiring dental implants in previously horizontally augmented bone crest are recruited at the Department of Periodon¬tics, Faculty of dental medicine, Saint-Joseph University, Beirut, and will be treated with either T3 (contemporary hybrid collar), tapered, ex-hex, CP4 or Full Osseotite, tapered, ex-hex, CP4. A total of 30 implants will be placed (15 per group). Random allocation of implant type per site will be done by the sealed envelope method. The implants will be placed using a one-stage surgical approach. A final crown will be placed (screw-retained on multiunit abutment) between 3 and 4 months post-implant placement. The patients will be followed-up at 6 months and 1 year. Only patients meeting inclusion/exclusion criteria and providing a dated and signed informed consent form will be enrolled in the study.

Interventions

In both groups, the implants will be placed using a two-stage surgical approach at the crestal level in previously horizontally augmented bony sites. A final crown will be placed (screw-retained on multiunit abutment) between 3- and 4-months post-implant placement. Random allocation of implant type per site will be done by the sealed envelope method. Follow-up measurements will be done at 6 months and 1-year post-loading. The measurements are done by a blinded investigator. Before starting the study, the examiner will be trained in a calibration process. Exam sheets are kept confidential and anonymous. Inclusion criteria are: patient aged 20 to 65, no systematic contraindication for implant surgery, smoking \< 10 cigarettes, previous horizontal bone augmentation, FMBS \<20% and FMPS \< 20%. Exclusion criteria are: general contraindication for implant surgery, pregnant/lactating women, uncontrolled diabetics, patients not willing to sign the consent form, active periodontitis.

Sponsors

Saint-Joseph University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patient age: between 20 and 65 * No systematic contraindication for implant surgery * No more than 10 cigarettes/day * Previous horizontal bone augmentation 6 months prior to implant placement * Adequate oral hygiene i.e. Full mouth bleeding score (FMBS) \<20% and Full mouth plaque score (FMPS) \< 20%)

Exclusion criteria

* Smokers more than 10 cigarettes/day * Pregnant/lactating women * Alcoholics/drug addicts * Uncontrolled diabetics, immunocompromised, blood hemostasis problems * Patients taking IV bisphosphonates or drugs affecting bone metabolism or mucosal healing * Patients not willing to sign the consent form * History of radiotherapy in the head and neck region in the last 5 years * Active periodontitis on the remaining teeth

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline of alveolar ridge thickness at 4 monthsDuring procedure and at 4 monthsPeroperative surgical measurements of the alveolar ridge width at implant sites
Change from baseline of radiographic bone level on CBCT at 1 year post-opDuring procedure and at 1 yearCBCT for buccal bone thickness measurements of the bone crest width at the implant site.
Change from baseline of radiographic bone level assessment at 1 year post-op, on periapical x-rayDuring procedure, at 4 months, at 6 months and 1 yearRadiographic measurements on standardized periapical radiograph of the bone dimensions, for interproximal bone remodeling, from the shoulder of the implant (reference point), to the coronal bone to implant contact
Change from baseline of bone plate thickness at 4 monthsDuring procedure and at 4 monthsPeroperative buccal and lingual residual bone thickness following implant insertion

Secondary

MeasureTime frameDescription
Histological analysisDuring procedureBone core taken with a 2mm trephine bur at the site of implant placement for non-demineralized histological assessment of regenerated bone quality
Insertion torqueDuring procedureManual torque insertion are registered at implant placement.
Change of FMPS parameters from baseline to 1 year post-opDuring procedure, at 6 months and at 1 yearChange in full mouth plaque score
Change of Clinical parameters from baseline to 1 year post-opDuring procedure, at 6 months and at 1 yearFMBS, FMPS,
Change of FMBS parameters from baseline to 1 year post-opDuring procedure, at 6 months and at 1 yearChange in full mouth bleeding score
Change of Keratinized tissue height from Baseline to 4 monthsDuring procedure and at 4 monthsMeasured using a 1.0-mm marked periodontal probe

Countries

Lebanon

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026